A diagnostic test developed by a startup in Ribeirão Preto, in the interior of the state of São Paulo, Brazil, helps identify and classify thyroid nodules. The test prevents patients with suspected ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced new research findings suggesting the potential of novel molecular ...
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...
Thyroid nodules initially diagnosed on fine needle aspiration (FNA) cytology to be indeterminate rarely have a change in management after repeat FNA, suggesting little benefit in repeat testing of the ...
A molecular signature that predicts aggressive thyroid cancer could help guide treatment approaches for patients, according to a study published in the journal Cell Genomics. A multidisciplinary team ...
Feasibility of a combined surgery-focused lay navigation and enhanced recovery program (ERP) for gastrointestinal (GI) cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Quality Care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results